MediciNova, Inc. acquires, develops, and commercializes small molecule therapeutics. The Company, through alliances with Japanese pharmaceutical companies, has built a portfolio of drug candidates. MediciNova researches treatments for asthma, status asthmaticus, insomnia, interstitial cystitis, cancer, multiple sclerosis, preterm labor, urinary incontinence, and anxiety.